Healthcare
The healthcare sector remains one of the fastest growing parts of the global economy and one of the biggest challenges facing policy makers and the private sector. The cost of healthcare continues to outpace inflation in virtually every country in the world, and efforts at reform and cost containment make operating a commercial venture in the sector a continually dynamic enterprise. Despite the challenges, though, the sector holds great opportunities driven by the aging population in developed countries, increasing demand for sophisticated therapies and care systems in developing countries, rapidly advancing health technologies.
The healthcare category covers the array of market products and services that form the environment in which clinical care is provided, including the financial side of medical markets from private healthcare financing (insurance, managed care, and reimbursement schemes) to public regulation and policy (government programs and subsidies). It also covers issues in care delivery and settings (hospitals, clinics, long-term care facilities, personnel, improvement initiatives, and prevention/wellness programs) and technological product categories that will impact the entire system (hospital information systems, telemedicine, and electronic medical records [EMR]).
The healthcare category covers the array of market products and services that form the environment in which clinical care is provided, including the financial side of medical markets from private healthcare financing (insurance, managed care, and reimbursement schemes) to public regulation and policy (government programs and subsidies). It also covers issues in care delivery and settings (hospitals, clinics, long-term care facilities, personnel, improvement initiatives, and prevention/wellness programs) and technological product categories that will impact the entire system (hospital information systems, telemedicine, and electronic medical records [EMR]).
Page 12/13
GTC Biotherapeutics, Inc. (formerly Genzyme Transgenics Corp.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Peregrine Pharmaceuticals, Inc. (formerly Techniclone Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Algeta ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Metabolex, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Amorfix Life Sciences, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Sequella, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Response Genetics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Endocyte, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
ZIOPHARM Oncology, Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Proteome Sciences plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
BIND Biosciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Argos Therapeutics, Inc. (Formerly Merix Bioscience) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
NanoInk, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Cerus Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Optimer Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Scil Biomedicals GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Vernalis plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Oramed Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Pure Bioscience - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Oxygen Biotherapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
KINAXO Biotechnologies GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
BioAlliance Pharma SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Helicos BioSciences Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Human Genome Sciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Array BioPharma, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Achillion Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Somaxon Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
EXACT Sciences Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Pharmasset, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Alimera Sciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
BioInvent International AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Xoft, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Athersys, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Aldagen, Inc. (formerly Stemco Biomedical, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
MAKO Surgical Corp. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Icagen, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Emisphere Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Evogene, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Grunenthal GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Orthofix International N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
BASF Plant Science GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Millennium Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
ImClone Systems Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
DxS, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Caraco Pharmaceutical Laboratories, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
January 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Cubist Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report
December 2012 · MarketLine
Cubist Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Philips Healthcare - SWOT, Strategy and Corporate Finance Report
December 2012 · MarketLine
Philips Healthcare - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Recordati S.p.A. - SWOT, Strategy and Corporate Finance Report
December 2012 · MarketLine
Recordati S.p.A. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Celgene Corporation - SWOT, Strategy and Corporate Finance Report
December 2012 · MarketLine
Celgene Corporation - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
St. Jude Medical, Inc. - SWOT, Strategy and Corporate Finance Report
December 2012 · MarketLine
St. Jude Medical, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc. € 129,00
Options